You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MGMT

Showing 1 - 25 of 289
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Glioblastoma Trial (Azeliragon)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Aug 3, 2023

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
Has Results
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

First Progression of MGMT Promoter-methylated Glioblastoma Trial in Bellinzona, Zürich (Lomustine, Romiplostim)

Recruiting
  • First Progression of MGMT Promoter-methylated Glioblastoma
  • Barcelona, Spain
  • +4 more
Nov 16, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

Not yet recruiting
  • Glioblastoma
  • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
  • Gainesville, Florida
    University of Florida Health
Jul 29, 2022

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Colorectal Cancer Trial (Irinotecan, Temozolomide)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 1, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

O6-methylguanine-DNA Methyltransferase Promoter Methylation and

Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
May 14, 2021

Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)

Not yet recruiting
  • Glioblastoma
  • Dose escalation of radiation dose beyond the therapeutic standard
  • (no location specified)
May 13, 2023

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

MGMT-Unmethylated Glioblastoma Trial in Nanjing (Anlotinib, AK105, Radiotherapy)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 27, 2021

Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

Completed
  • Metastatic Colorectal Cancer
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023